Transcriptional regulation of human microsomal triglyceride transfer protein by hepatocyte nuclear factor-4α

Microsomal triglyceride transfer protein (MTP) catalyzes the assembly of triglyceride (TG)-rich apolipoprotein B-containing liver (e.g., VLDL) and intestinal (e.g., chylomicron) lipoproteins. The human MTP gene promoter is reported here to associate in vivo with endogenous hepatocyte nuclear factor-4alpha (HNF-4alpha) and to be transactivated or transsuppressed by overexpressed or by dominant negative HNF-4alpha, respectively. Human MTP (hMTP) transactivation by HNF-4alpha is accounted for by the concerted activity of distal (- 83/ - 70) and proximal (- 50/ - 38) direct repeat 1 elements of the hMTP promoter that bind HNF-4alpha. Transactivation by HNF-4alpha is specifically antagonized by chicken ovalbumin upstream promoter. Transcriptional activation of hMTP by HNF-4alpha is mediated by HNF-4alpha domains engaged in ligand binding and ligand-driven transactivation and is further complemented by HNF-4alpha/HNF-1alpha synergism that involves the HNF-4alpha(x activation function 1 (AF-1) domain. hMTP transactivation by HNF-4alpha(x is specifically inhibited by P,R-tetramethyl-hexadecanedioic acid acting as an HNF-4alpha antagonist ligand.jlr hMTP transactivation by HNF-4alpha may account for the activation or inhibition of MTP expression and the production of TG-rich lipoproteins by agonist (e.g., saturated fatty acids) or antagonist [e.g., (n-3) PUFA, hypolipidemic fibrates, or Methyl-substituted dicarboxylic acid (Medica) compounds] HNF-4alpha ligands.-Sheena, V, R. Hertzj Nousbeck, I. Berman,. Magenheim, and J. Bar-Tana. Transcriptional regulation of human microsomal triglyceride transfer protein by hepatocyte nuclear factor-4alpha.